




Searching News Database: headache
Your search returned too many results! The most recent 500 items are shown below:
HSMN NewsFeed - 31 Jan 2025
U.S. FDA Approves Celltrion's AVTOZMA(R) (tocilizumab-anoh), a Biosimilar to ACTEMRA(R)
U.S. FDA Approves Celltrion's AVTOZMA(R) (tocilizumab-anoh), a Biosimilar to ACTEMRA(R)
HSMN NewsFeed - 9 May 2023
Omeq Medical Receives FDA Regulatory Clearance for its Smart Device for Epidural Injections
Omeq Medical Receives FDA Regulatory Clearance for its Smart Device for Epidural Injections
HSMN NewsFeed - 15 Jun 2022
RADICAVA ORS(R) (edaravone) Now Available in the U.S. for the Treatment of ALS
RADICAVA ORS(R) (edaravone) Now Available in the U.S. for the Treatment of ALS
HSMN NewsFeed - 28 Mar 2022
Jazz Pharmaceuticals Announces Agreement to Divest Sunosi(R) (solriamfetol) to Axsome Therapeutics
Jazz Pharmaceuticals Announces Agreement to Divest Sunosi(R) (solriamfetol) to Axsome Therapeutics
HSMN NewsFeed - 8 Nov 2021
Azurity Pharmaceuticals, Inc. Announces FDA Approval of Eprontia(TM) (Topiramate) Oral Solution
Azurity Pharmaceuticals, Inc. Announces FDA Approval of Eprontia(TM) (Topiramate) Oral Solution
HSMN NewsFeed - 31 Aug 2021
MicroTransponder(R) Receives FDA Approval for Breakthrough Device Benefiting Stroke Survivors
MicroTransponder(R) Receives FDA Approval for Breakthrough Device Benefiting Stroke Survivors
HSMN NewsFeed - 17 Jun 2021
Lilly Launches Think Talk Treat Migraine(TM) to Help Improve Diagnosis and Treatment of Migraine
Lilly Launches Think Talk Treat Migraine(TM) to Help Improve Diagnosis and Treatment of Migraine
HSMN NewsFeed - 20 Apr 2021
Lilly and Incyte's Baricitinib Improved Hair Regrowth for Alopecia Areata Patients in Second Phase 3 Study
Lilly and Incyte's Baricitinib Improved Hair Regrowth for Alopecia Areata Patients in Second Phase 3 Study
HSMN NewsFeed - 17 Mar 2021
MagVenture introduces new solution to improve the ease of use for non-invasive brain stimulation
MagVenture introduces new solution to improve the ease of use for non-invasive brain stimulation
HSMN NewsFeed - 24 Feb 2021
Clarus Therapeutics Appoints Richard 'Ric' Peterson as Chief Financial Officer
Clarus Therapeutics Appoints Richard 'Ric' Peterson as Chief Financial Officer
HSMN NewsFeed - 1 Feb 2021
Galderma Receives FDA Approval for Restylane(R) Defyne for Chin Augmentation
Galderma Receives FDA Approval for Restylane(R) Defyne for Chin Augmentation
HSMN NewsFeed - 25 Jan 2021
FDA Approves Theranica's Nerivio(R) for Acute Treatment of Migraine in Adolescents
FDA Approves Theranica's Nerivio(R) for Acute Treatment of Migraine in Adolescents
HSMN NewsFeed - 17 Dec 2020
FDA Approves GSK's BENLYSTA as the First Medicine for Adult Patients with Active Lupus Nephritis in the US
FDA Approves GSK's BENLYSTA as the First Medicine for Adult Patients with Active Lupus Nephritis in the US
HSMN NewsFeed - 1 Dec 2020
Novartis announces FDA approval of Xolair(R) (omalizumab) for adults with nasal polyps
Novartis announces FDA approval of Xolair(R) (omalizumab) for adults with nasal polyps
HSMN NewsFeed - 18 Jun 2020
Almirall Announces FDA Approval Of Updated Label For Seysara(R) (Sarecycline) Tablets
Almirall Announces FDA Approval Of Updated Label For Seysara(R) (Sarecycline) Tablets
HSMN NewsFeed - 14 May 2020
Olympic Ophthalmics Receives FDA Clearance for iTEAR100(R) Neurostimulator
Olympic Ophthalmics Receives FDA Clearance for iTEAR100(R) Neurostimulator
HSMN NewsFeed - 22 Apr 2020
Novartis Kymriah(R) receives FDA Regenerative Medicine Advanced Therapy designation in follicular lymphoma
Novartis Kymriah(R) receives FDA Regenerative Medicine Advanced Therapy designation in follicular lymphoma
HSMN NewsFeed - 13 Mar 2020
EMD Serono and Pfizer Provide Update on Phase III JAVELIN Head and Neck 100 Study
EMD Serono and Pfizer Provide Update on Phase III JAVELIN Head and Neck 100 Study
HSMN NewsFeed - 18 Nov 2019
Allergan(R) Announces First Annual National BOTOX(R) Cosmetic (onabotulinumtoxinA) Day
Allergan(R) Announces First Annual National BOTOX(R) Cosmetic (onabotulinumtoxinA) Day
HSMN NewsFeed - 18 Oct 2019
Nplate(R) (romiplostim) Now Approved For Earlier Use In Adults With Immune Thrombocytopenia
Nplate(R) (romiplostim) Now Approved For Earlier Use In Adults With Immune Thrombocytopenia
HSMN NewsFeed - 10 Oct 2019
FDA Grants Ofev(R) Breakthrough Therapy Designation for Chronic Fibrosing ILDs with a Progressive Phenotype
FDA Grants Ofev(R) Breakthrough Therapy Designation for Chronic Fibrosing ILDs with a Progressive Phenotype
HSMN NewsFeed - 12 Jul 2019
Lilly's OVERCOME Observational Study Reveals Inconsistent and Sub-Optimal Treatment Landscape for Migraine
Lilly's OVERCOME Observational Study Reveals Inconsistent and Sub-Optimal Treatment Landscape for Migraine
HSMN NewsFeed - 28 Jun 2019
Amgen and UCB Provide Regulatory Update on Status of EVENITY(TM) (romosozumab) in the EU
Amgen and UCB Provide Regulatory Update on Status of EVENITY(TM) (romosozumab) in the EU
HSMN NewsFeed - 26 Jun 2019
U.S. FDA Grants Fast Track Designation to Empagliflozin for the Treatment of Chronic Heart Failure
U.S. FDA Grants Fast Track Designation to Empagliflozin for the Treatment of Chronic Heart Failure
HSMN NewsFeed - 21 Jun 2019
FDA Approves BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Upper Limb Spasticity
FDA Approves BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Upper Limb Spasticity
HSMN NewsFeed - 28 May 2019
FDA Grants Theranica De Novo to Market First Smartphone-controlled Acute Migraine-relief Wearable Device
FDA Grants Theranica De Novo to Market First Smartphone-controlled Acute Migraine-relief Wearable Device
HSMN NewsFeed - 11 Mar 2019
Allergan Announces FDA Acceptance of New Drug Application for Ubrogepant for the Acute Treatment of Migraine
Allergan Announces FDA Acceptance of New Drug Application for Ubrogepant for the Acute Treatment of Migraine
HSMN NewsFeed - 18 Jan 2019
Lilly Reports Results of Phase 3 Soft Tissue Sarcoma Study of LARTRUVO(R)
Lilly Reports Results of Phase 3 Soft Tissue Sarcoma Study of LARTRUVO(R)
HSMN NewsFeed - 10 Dec 2018
Biohaven Announces Positive Results from Ongoing Rimegepant Long-Term Safety Study
Biohaven Announces Positive Results from Ongoing Rimegepant Long-Term Safety Study
HSMN NewsFeed - 5 Nov 2018
Galderma Announces FDA Approval of Restylane(R) Lyft For Midface Injection via Cannula
Galderma Announces FDA Approval of Restylane(R) Lyft For Midface Injection via Cannula
HSMN NewsFeed - 23 Aug 2018
IDELVION(R) 3500 IU Vials Now Available to Provide Convenience to Patients
IDELVION(R) 3500 IU Vials Now Available to Provide Convenience to Patients
HSMN NewsFeed - 17 Aug 2018
FDA permits marketing of transcranial magnetic stimulation for treatment of obsessive compulsive disorder
FDA permits marketing of transcranial magnetic stimulation for treatment of obsessive compulsive disorder
HSMN NewsFeed - 8 Aug 2018
United Therapeutics Announces FREEDOM-EV Study Of Orenitram Meets Primary Endpoint
United Therapeutics Announces FREEDOM-EV Study Of Orenitram Meets Primary Endpoint
HSMN NewsFeed - 29 Jun 2018
Amneal Announces Favorable Ruling Regarding Patent Validity for Zomig(R) (zolmitriptan) Nasal Spray
Amneal Announces Favorable Ruling Regarding Patent Validity for Zomig(R) (zolmitriptan) Nasal Spray
HSMN NewsFeed - 8 Jun 2018
European Commission Approves Prolia(R) (denosumab) for Patients With Glucocorticoid-Induced Osteoporosis
European Commission Approves Prolia(R) (denosumab) for Patients With Glucocorticoid-Induced Osteoporosis
HSMN NewsFeed - 30 May 2018
FDA expedites review of Novartis drug Promacta(R) for first-line severe aplastic anemia (SAA)
FDA expedites review of Novartis drug Promacta(R) for first-line severe aplastic anemia (SAA)
HSMN NewsFeed - 18 May 2018
FDA Approves Aimovig(TM) (erenumab-aooe), A Novel Treatment Developed Specifically For Migraine Prevention
FDA Approves Aimovig(TM) (erenumab-aooe), A Novel Treatment Developed Specifically For Migraine Prevention
HSMN NewsFeed - 26 Mar 2018
FDA approves inclusion of data from safety outcomes trial in the Tresiba(R) label
FDA approves inclusion of data from safety outcomes trial in the Tresiba(R) label
HSMN NewsFeed - 5 Mar 2018
U.S. FDA Accepts New Drug Application for Prucalopride (SHP555) for Chronic Idiopathic Constipation
U.S. FDA Accepts New Drug Application for Prucalopride (SHP555) for Chronic Idiopathic Constipation
HSMN NewsFeed - 10 Jan 2018
BYDUREON(R) BCise(TM) Injectable Medicine Now Available In The US For Patients With Type-2 Diabetes
BYDUREON(R) BCise(TM) Injectable Medicine Now Available In The US For Patients With Type-2 Diabetes
HSMN NewsFeed - 18 Dec 2017
Novartis multiple sclerosis therapy fingolimod granted FDA Breakthrough Therapy designation for pediatric MS
Novartis multiple sclerosis therapy fingolimod granted FDA Breakthrough Therapy designation for pediatric MS
HSMN NewsFeed - 7 Dec 2017
John Walsh, M.D. Joins EMD Serono as Vice President of Neurology & Immunology, US Medical Affairs
John Walsh, M.D. Joins EMD Serono as Vice President of Neurology & Immunology, US Medical Affairs
HSMN NewsFeed - 1 Dec 2017
FDA approves first biosimilar for the treatment of certain breast and stomach cancers
FDA approves first biosimilar for the treatment of certain breast and stomach cancers
HSMN NewsFeed - 20 Nov 2017
United Therapeutics Announces Additional Six Months Of Regulatory Exclusivity For Adcirca(R)
United Therapeutics Announces Additional Six Months Of Regulatory Exclusivity For Adcirca(R)
HSMN NewsFeed - 16 Nov 2017
FDA Approves New Treatment to Prevent Bleeding in Certain Patients with Hemophilia A
FDA Approves New Treatment to Prevent Bleeding in Certain Patients with Hemophilia A
HSMN NewsFeed - 14 Nov 2017
FDA warns about illegal use of injectable silicone for body contouring and associated health risks
FDA warns about illegal use of injectable silicone for body contouring and associated health risks
HSMN NewsFeed - 23 Oct 2017
United Therapeutics Announces FDA Approval of Third Generation Nebulizer for the Tyvaso(R) Inhalation System
United Therapeutics Announces FDA Approval of Third Generation Nebulizer for the Tyvaso(R) Inhalation System
HSMN NewsFeed - 20 Oct 2017
Celgene Provides Update on GED-0301 (mongersen) Inflammatory Bowel Disease Program
Celgene Provides Update on GED-0301 (mongersen) Inflammatory Bowel Disease Program
HSMN NewsFeed - 28 Sep 2017
AbbVie Announces Global Resolution of HUMIRA(R) (adalimumab) Patent Disputes with Amgen
AbbVie Announces Global Resolution of HUMIRA(R) (adalimumab) Patent Disputes with Amgen
HSMN NewsFeed - 7 Sep 2017
eNeura, Inc. Receives FDA Clearance for Use of SpringTMS(R) for Migraine Prevention
eNeura, Inc. Receives FDA Clearance for Use of SpringTMS(R) for Migraine Prevention
HSMN NewsFeed - 21 Jul 2017
Lexicon Collaborator Ipsen Receives Positive CHMP Opinion For Xermelo(R) (Telotristat Ethyl)
Lexicon Collaborator Ipsen Receives Positive CHMP Opinion For Xermelo(R) (Telotristat Ethyl)
HSMN NewsFeed - 4 Jul 2017
FDA Clears Expanded Use of Cooling Cap to Reduce Hair Loss During Chemotherapy
FDA Clears Expanded Use of Cooling Cap to Reduce Hair Loss During Chemotherapy
HSMN NewsFeed - 13 Apr 2017
RedHill Biopharma and IntelGenx Announce Marketing Approval of RIZAPORT(R) for Migraines in Luxembourg
RedHill Biopharma and IntelGenx Announce Marketing Approval of RIZAPORT(R) for Migraines in Luxembourg
HSMN NewsFeed - 7 Apr 2017
Medtronic Announces Voluntary Worldwide Recall of its StrataMR(TM) Adjustable Valves and Shunts
Medtronic Announces Voluntary Worldwide Recall of its StrataMR(TM) Adjustable Valves and Shunts
HSMN NewsFeed - 17 Feb 2017
LYNPARZA(TM) (olaparib) Meets Primary Endpoint in Phase III Trial in BRCA-Mutated Metastatic Breast Cancer
LYNPARZA(TM) (olaparib) Meets Primary Endpoint in Phase III Trial in BRCA-Mutated Metastatic Breast Cancer
HSMN NewsFeed - 16 Feb 2017
Valeant Receives FDA Approval Of SILIQ(TM) (Brodalumab) For Moderate-To-Severe Plaque Psoriasis
Valeant Receives FDA Approval Of SILIQ(TM) (Brodalumab) For Moderate-To-Severe Plaque Psoriasis
HSMN NewsFeed - 18 Jan 2017
Lilly and CoLucid Pharmaceuticals Announce Agreement for Lilly To Acquire CoLucid
Lilly and CoLucid Pharmaceuticals Announce Agreement for Lilly To Acquire CoLucid
HSMN NewsFeed - 27 Dec 2016
Shire Announces FDA Approval of Adynovate(R) for use in Children and Surgical Settings
Shire Announces FDA Approval of Adynovate(R) for use in Children and Surgical Settings
HSMN NewsFeed - 31 Oct 2016
Antares Pharma Appoints Fred M. Powell, Senior Vice President and Chief Financial Officer
Antares Pharma Appoints Fred M. Powell, Senior Vice President and Chief Financial Officer
HSMN NewsFeed - 24 Oct 2016
Efficacy of Ofev(R) (nintedanib) Reinforced in Range of Patients with IPF in New Analyses Presented at CHEST
Efficacy of Ofev(R) (nintedanib) Reinforced in Range of Patients with IPF in New Analyses Presented at CHEST
HSMN NewsFeed - 6 Oct 2016
U.S. FDA Approves Orexo's Low Dose ZUBSOLV(R) Buprenorphine and Naloxone Sublingual Tablets (CIII)
U.S. FDA Approves Orexo's Low Dose ZUBSOLV(R) Buprenorphine and Naloxone Sublingual Tablets (CIII)
HSMN NewsFeed - 31 Aug 2016
Allergan and Adamas Announce Settlement with Amneal Related to NAMZARIC(R) Patent Litigation
Allergan and Adamas Announce Settlement with Amneal Related to NAMZARIC(R) Patent Litigation
HSMN NewsFeed - 1 Aug 2016
Orexigen Completes Acquisition of All U.S. Rights to Contrave(R) and Launches U.S. Sales Organization
Orexigen Completes Acquisition of All U.S. Rights to Contrave(R) and Launches U.S. Sales Organization
HSMN NewsFeed - 1 Aug 2016
Shire Announces FDA Approval of adynovate with BAXJECT III Reconstitution System
Shire Announces FDA Approval of adynovate with BAXJECT III Reconstitution System
HSMN NewsFeed - 20 Jul 2016
Acclarent Announces U.S. Launch of RELIEVA SCOUT(R) Multi-Sinus Dilation System
Acclarent Announces U.S. Launch of RELIEVA SCOUT(R) Multi-Sinus Dilation System
HSMN NewsFeed - 1 Jul 2016
Valeant Pharmaceuticals Announces New Licensing Arrangement For Brodalumab In Europe
Valeant Pharmaceuticals Announces New Licensing Arrangement For Brodalumab In Europe
HSMN NewsFeed - 8 Jun 2016
Orexigen Therapeutics Reports Favorable Markman Ruling in Contrave(R) Patent Litigation
Orexigen Therapeutics Reports Favorable Markman Ruling in Contrave(R) Patent Litigation
HSMN NewsFeed - 13 May 2016
Alprolix(R) (rFIXFc) approved in the EU for the treatment of haemophilia B
Alprolix(R) (rFIXFc) approved in the EU for the treatment of haemophilia B
HSMN NewsFeed - 21 Apr 2016
eNeura, Inc. Receives CE Mark Label Extension Expanding Use of SpringTMS(R) to Include Migraine Prevention
eNeura, Inc. Receives CE Mark Label Extension Expanding Use of SpringTMS(R) to Include Migraine Prevention
HSMN NewsFeed - 13 Apr 2016
Autonomic Technologies Appoints Niamh Pellegrini as President and Chief Executive Officer
Autonomic Technologies Appoints Niamh Pellegrini as President and Chief Executive Officer
HSMN NewsFeed - 12 Apr 2016
Autonomic Technologies Appoints Niamh Pellegrini as President and Chief Executive Officer
Autonomic Technologies Appoints Niamh Pellegrini as President and Chief Executive Officer
HSMN NewsFeed - 24 Mar 2016
Pivotal Phase III Trial of enzalutamide Initiated in Metastatic Hormone Sensitive Prostate Cancer
Pivotal Phase III Trial of enzalutamide Initiated in Metastatic Hormone Sensitive Prostate Cancer
HSMN NewsFeed - 15 Mar 2016
CoLucid Pharmaceuticals Announces Election of Alison Lawton to Board of Directors
CoLucid Pharmaceuticals Announces Election of Alison Lawton to Board of Directors
HSMN NewsFeed - 3 Mar 2016
Allergan Launches Bold Access To LILETTA(R) (levonorgestrel-releasing intrauterine system)
Allergan Launches Bold Access To LILETTA(R) (levonorgestrel-releasing intrauterine system)
HSMN NewsFeed - 22 Feb 2016
Endo Announces Launch Of BELBUCA(TM) (Buprenorphine) Buccal Film For Chronic Pain Management
Endo Announces Launch Of BELBUCA(TM) (Buprenorphine) Buccal Film For Chronic Pain Management
HSMN NewsFeed - 26 Jan 2016
Novo Nordisk Launches Tresiba(R) (insulin degludec injection 200 Units/mL) in the United States
Novo Nordisk Launches Tresiba(R) (insulin degludec injection 200 Units/mL) in the United States
HSMN NewsFeed - 25 Jan 2016
Valeant Announces FDA Acceptance of BLA Submission for Brodalumab in Moderate-to-Severe Plaque Psoriasis
Valeant Announces FDA Acceptance of BLA Submission for Brodalumab in Moderate-to-Severe Plaque Psoriasis
HSMN NewsFeed - 22 Jan 2016
U.S. FDA Approves BOTOX(R) (onabotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Adults
U.S. FDA Approves BOTOX(R) (onabotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Adults
HSMN NewsFeed - 21 Jan 2016
Allergan Announces FDA Approval of Updated Label for New Dosing Regimen for DALVANCE(R) (dalbavancin)
Allergan Announces FDA Approval of Updated Label for New Dosing Regimen for DALVANCE(R) (dalbavancin)
HSMN NewsFeed - 15 Jan 2016
Impax Receives Approval of EMVERM(TM) (mebendazole) Chewable Tablets, 100 mg
Impax Receives Approval of EMVERM(TM) (mebendazole) Chewable Tablets, 100 mg
HSMN NewsFeed - 24 Nov 2015
Sobi and Biogen’s ELOCTA(R) (rFVIIIFc) Approved in Europe for the Treatment of Haemophilia A
Sobi and Biogen’s ELOCTA(R) (rFVIIIFc) Approved in Europe for the Treatment of Haemophilia A
HSMN NewsFeed - 27 Oct 2015
CoLucid Pharmaceuticals Announces Election of Mark Corrigan, M.D., to Board of Directors
CoLucid Pharmaceuticals Announces Election of Mark Corrigan, M.D., to Board of Directors
HSMN NewsFeed - 26 Oct 2015
U.S. FDA Approves BELBUCA(TM) (buprenorphine) Buccal Film for Chronic Pain Management
U.S. FDA Approves BELBUCA(TM) (buprenorphine) Buccal Film for Chronic Pain Management
HSMN NewsFeed - 1 Oct 2015
BioMarin to Acquire Rights to Phenylketonuria (PKU) Franchise From Merck Serono
BioMarin to Acquire Rights to Phenylketonuria (PKU) Franchise From Merck Serono
HSMN NewsFeed - 15 Sep 2015
FDA Approves Octapharma’s NUWIQ for the Treatment of Adults and Children with Hemophilia
FDA Approves Octapharma’s NUWIQ for the Treatment of Adults and Children with Hemophilia
HSMN NewsFeed - 4 Aug 2015
Trigemina Appoints Dr. Shashi Kori to the Position of Chief Medical Officer
Trigemina Appoints Dr. Shashi Kori to the Position of Chief Medical Officer
HSMN NewsFeed - 9 Jul 2015
The Medicines Company Authorizes Generic Launch of ANGIOMAX(R) (bivalirudin)
The Medicines Company Authorizes Generic Launch of ANGIOMAX(R) (bivalirudin)
HSMN NewsFeed - 25 Jun 2015
Autonomic Technologies Completes Transatlantic Series D Financing of $43.2M
Autonomic Technologies Completes Transatlantic Series D Financing of $43.2M
HSMN NewsFeed - 12 Jun 2015
FDA Approves Promacta(R) for New Pediatric Chronic Immune Thrombocytopenia (cITP) Indication
FDA Approves Promacta(R) for New Pediatric Chronic Immune Thrombocytopenia (cITP) Indication
HSMN NewsFeed - 1 Jun 2015
POZEN Announces Retirement of Founder, Chairman and CEO Dr. John R. Plachetka; Adrian Adams Named as CEO
POZEN Announces Retirement of Founder, Chairman and CEO Dr. John R. Plachetka; Adrian Adams Named as CEO
HSMN NewsFeed - 12 May 2015
Autonomic Technologies Raises USD 38M in a Transatlantic Series D Financing
Autonomic Technologies Raises USD 38M in a Transatlantic Series D Financing
HSMN NewsFeed - 19 Mar 2015
Daiichi Sankyo Signs Agreement With AstraZeneca To Co-Commercialize MOVANTIK In The US
Daiichi Sankyo Signs Agreement With AstraZeneca To Co-Commercialize MOVANTIK In The US
HSMN NewsFeed - 13 Feb 2015
Entellus Medical Announces Release of XprESS(TM) Ultra Multi-Sinus Dilation System
Entellus Medical Announces Release of XprESS(TM) Ultra Multi-Sinus Dilation System
HSMN NewsFeed - 12 Dec 2014
Sanofi Pasteur Announces FDA Approval of Fluzone(R) Intradermal Quadrivalent (Influenza Vaccine) for Adults
Sanofi Pasteur Announces FDA Approval of Fluzone(R) Intradermal Quadrivalent (Influenza Vaccine) for Adults
HSMN NewsFeed - 10 Nov 2014
NeoTract, Inc. Announces CMS Reimbursement for Innovative Minimally Invasive Procedure for Enlarged Prostate
NeoTract, Inc. Announces CMS Reimbursement for Innovative Minimally Invasive Procedure for Enlarged Prostate
HSMN NewsFeed - 5 Nov 2014
Ipsen Biopharmaceuticals, Inc. Announces Hire of Donald Pearl as Vice President of Neurology
Ipsen Biopharmaceuticals, Inc. Announces Hire of Donald Pearl as Vice President of Neurology
HSMN NewsFeed - 30 Oct 2014
U.S. FDA Approves Once-Daily XIGDUO(TM) XR Tablets for Adults with Type 2 Diabetes
U.S. FDA Approves Once-Daily XIGDUO(TM) XR Tablets for Adults with Type 2 Diabetes
HSMN NewsFeed - 19 Aug 2014
FDA Approves Use of AFLURIA(R) Influenza Vaccine with PharmaJet’s Needle-Free Injector
FDA Approves Use of AFLURIA(R) Influenza Vaccine with PharmaJet’s Needle-Free Injector
HSMN NewsFeed - 14 Aug 2014
FDA Approves Genentech’s Avastin Plus Chemotherapy for Treatment of Advanced Cervical Cancer
FDA Approves Genentech’s Avastin Plus Chemotherapy for Treatment of Advanced Cervical Cancer
HSMN NewsFeed - 22 Jul 2014
FDA Grants Genentech’s Avastin Priority Review for Recurrent Platinum-Resistant Ovarian Cancer
FDA Grants Genentech’s Avastin Priority Review for Recurrent Platinum-Resistant Ovarian Cancer
HSMN NewsFeed - 15 Jul 2014
FDA Grants Genentech’s Avastin Priority Review for Certain Types of Cervical Cancer
FDA Grants Genentech’s Avastin Priority Review for Certain Types of Cervical Cancer
HSMN NewsFeed - 11 Jun 2014
Lilly Announces Top-Line Results Of Phase III Hepatocellular Carcinoma Trial
Lilly Announces Top-Line Results Of Phase III Hepatocellular Carcinoma Trial
HSMN NewsFeed - 5 Jun 2014
ORBACTIV(TM) (Oritavancin) Phase 3 Trial Results Published in New England Journal of Medicine
ORBACTIV(TM) (Oritavancin) Phase 3 Trial Results Published in New England Journal of Medicine
HSMN NewsFeed - 27 May 2014
Spinifex Pharmaceuticals Strengthens Scientific Advisory Board (SAB) with Experts in Chronic Pain
Spinifex Pharmaceuticals Strengthens Scientific Advisory Board (SAB) with Experts in Chronic Pain
HSMN NewsFeed - 23 May 2014
eNeura, Inc. Receives FDA Clearance for SpringTMS(R) Migraine Treatment Device
eNeura, Inc. Receives FDA Clearance for SpringTMS(R) Migraine Treatment Device
HSMN NewsFeed - 23 May 2014
Teva Received FDA Approval for QVAR(R) (beclomethasone dipropionate HFA) with Dose Counter
Teva Received FDA Approval for QVAR(R) (beclomethasone dipropionate HFA) with Dose Counter
HSMN NewsFeed - 14 May 2014
POZEN Announces U.S. Rights for Treximet(R) to Be Acquired by Pernix Therapeutics
POZEN Announces U.S. Rights for Treximet(R) to Be Acquired by Pernix Therapeutics
HSMN NewsFeed - 28 Apr 2014
Cyberonics Names Rohan Hoare, Ph.D. Chief Operating Officer And O'Neill D'Cruz, M.D. Chief Medical Officer
Cyberonics Names Rohan Hoare, Ph.D. Chief Operating Officer And O'Neill D'Cruz, M.D. Chief Medical Officer
HSMN NewsFeed - 24 Mar 2014
Health Canada Approves Biogen Idec's Long-Acting ALPROLIX(TM) Therapy for Hemophilia B
Health Canada Approves Biogen Idec's Long-Acting ALPROLIX(TM) Therapy for Hemophilia B
HSMN NewsFeed - 19 Mar 2014
Mallinckrodt plc Completes $1.4 Billion Acquisition of Cadence Pharmaceuticals, Inc.
Mallinckrodt plc Completes $1.4 Billion Acquisition of Cadence Pharmaceuticals, Inc.
HSMN NewsFeed - 11 Feb 2014
Mallinckrodt plc to Acquire Cadence Pharmaceuticals, Inc. for $14.00 Per Share, in Cash
Mallinckrodt plc to Acquire Cadence Pharmaceuticals, Inc. for $14.00 Per Share, in Cash
Additional items found! 500

Members Archive contains
500 additional stories matching:
headache
(Password required)
headache
(Password required)